Filing Details
- Accession Number:
- 0001209191-20-042310
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-13 18:45:35
- Reporting Period:
- 2020-07-09
- Accepted Time:
- 2020-07-13 18:45:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1503802 | Karyopharm Therapeutics Inc. | KPTI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1364719 | Michael Kauffman | C/O Karyopharm Therapeutics Inc. 85 Wells Avenue Newton MA 02459 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-10 | 7,500 | $4.75 | 562,622 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-10 | 7,200 | $18.98 | 555,422 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-10 | 300 | $19.71 | 555,122 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-09 | 7,500 | $4.75 | 763,989 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2020-07-09 | 7,500 | $19.53 | 756,489 | No | 4 | S | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-07-10 | 7,500 | $0.00 | 7,500 | $4.75 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-07-09 | 7,500 | $0.00 | 7,500 | $4.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 333,561 | 2023-09-02 | No | 4 | M | Direct | |
| 377,803 | 2023-09-02 | No | 4 | M | Indirect |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.67 to $19.64, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.69 to $19.73, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.30 to $19.75, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
